ADHD medication unlikely to raise risk of self-harm, international study finds
The risk of self-harm among people with attention deficit hyperactivity disorder (ADHD) is highest before people start ADHD medication, rather than after treatment begins, according to new research led by Aston University and recently published in the journal BMJ Mental Health.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Clinical support tool helps primary care health professionals detect and treat chronic kidney disease
United Kingdom
-
Potassium binder may ease the burden of dietary potassium restriction in people on dialysis
United Kingdom
-
Fruits and vegetables outperform medication for treating metabolic acidosis in chronic kidney disease
United Kingdom
-
Social determinants linked with kidney failure risk among survivors of critical illness and acute kidney injury
United Kingdom
-
Standardized kidney biopsy protocol is safe in high-risk patients
United Kingdom
-
US cannabis legalization linked to rise in cardiovascular hospital admissions
United Kingdom
-
Early uptake for oral semaglutide proves rapid relative to injectables
United Kingdom
-
Beyond the ACE score: A single number may miss the complexity of childhood trauma, study suggests
United Kingdom